XML 87 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Relevant Data Used to Estimate Fair Value of Stock Option Grants The relevant data used to determine the value of the stock option grants for the years ended December 31, 2019, 2018 and 2017 is as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Risk-free interest rates

 

1.42% - 2.67%

 

 

2.67% - 3.06%

 

 

1.97% - 2.29%

 

Expected dividend yield

 

0.00%

 

 

0.00%

 

 

0.00%

 

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

Expected volatility

 

66.2% - 69.5%

 

 

69.8% - 75.3%

 

 

69.9% - 72.8%

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the year ended December 31, 2019:

 

(In thousands, except per share amounts)

 

Shares Issuable

Under Options

 

 

Weighted Average

Exercise Price

 

Outstanding as of December 31, 2018

 

 

4,435

 

 

$

19.21

 

Granted

 

 

1,099

 

 

$

13.53

 

Exercised

 

 

(154

)

 

$

12.09

 

Cancelled

 

 

(605

)

 

$

20.31

 

Outstanding as of December 31, 2019

 

 

4,775

 

 

$

17.99

 

Options vested and expected to vest at December 31, 2019

 

 

4,775

 

 

$

17.99

 

Options exercisable at December 31, 2019

 

 

2,973

 

 

$

18.34

 

Summary of of RSU Activity

The following table summarizes the RSU activity for the year ended December 31, 2019:

 

(In thousands, except per share amounts)

 

Number of Shares

 

 

Weighted Average

Grant Date Fair Value Per Share

 

Nonvested balance as of December 31, 2018

 

 

252

 

 

$

22.25

 

Granted

 

 

873

 

 

 

14.51

 

Cancelled

 

 

(186

)

 

 

21.07

 

Vested/Released

 

 

(86

)

 

 

15.86

 

Nonvested balance as of December 31, 2019

 

 

853

 

 

$

15.84

 

Stock-Based Compensation Expense Related to Stock Options, Restricted Stock and Shares Purchased Under Employee Stock Purchase Plan

The Company recorded stock-based compensation expense related to stock options, restricted stock and shares purchased under the Employee Stock Purchase Plan for the years ended December 31, 2019, 2018 and 2017 as follows:

 

 

 

Year Ended December 31,

 

(In thousands)

 

2019

 

 

2018

 

 

2017

 

Research and development

 

$

5,211

 

 

$

4,728

 

 

$

3,979

 

Selling, general and administrative

 

 

10,690

 

 

 

10,731

 

 

 

7,563

 

Total

 

$

15,901

 

 

$

15,459

 

 

$

11,542